Levy Noah G. Insider Trades

Insider Trading History

Track insider trading activity for Levy Noah G.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $17M 1,119,586 shares
Last Trade
Jan 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.19M 100,000 shares
$11.90
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $15.4M 1,019,586 shares
Last Trade
Jan 03, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$59.6k 5,300 shares
$11.24
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $15.4M 1,014,286 shares
Last Trade
Dec 30, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.6k 1,300 shares
$11.24
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $11.4M 754,108 shares
Last Trade
Jul 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$18.2k 3,095 shares
$5.89
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $11.4M 751,013 shares
Last Trade
Jul 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$16.5k 2,816 shares
$5.86
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $11.3M 748,197 shares
Last Trade
Jul 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.18k 700 shares
$5.97
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $11.3M 747,497 shares
Last Trade
Jul 08, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.25k 1,378 shares
$5.99
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $11.3M 746,119 shares
Last Trade
Jul 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.59k 1,100 shares
$5.99
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $11.3M 745,019 shares
Last Trade
Jun 30, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.93k 1,550 shares
$5.76
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $11.3M 743,469 shares
Last Trade
Jun 24, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.99k 1,000 shares
$5.99
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $11.2M 742,469 shares
Last Trade
Jun 23, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3k 500 shares
$6.00
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $15.3M 1,012,986 shares
Last Trade
Jun 17, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.37k 900 shares
$5.97
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $15.3M 1,012,471 shares
Last Trade
Jun 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.83k 520 shares
$5.45
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $15.3M 1,012,174 shares
Last Trade
Jun 15, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15.6k 2,900 shares
$5.37
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $15.3M 1,010,515 shares
Last Trade
Jun 14, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$108k 20,938 shares
$5.17
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $15.1M 998,538 shares
Last Trade
Jun 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49.9k 9,699 shares
$5.15
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
other, See Remarks
Holding Value $15M 992,990 shares
Last Trade
Jun 10, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.4k 6,386 shares
$4.92
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $15M 989,337 shares
Last Trade
Jan 31, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.25k 1,237 shares
$5.05
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $15M 988,623 shares
Last Trade
Jan 28, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58.1k 12,963 shares
$4.48
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $10.8M 712,294 shares
Last Trade
Jan 27, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$78.4k 16,272 shares
$4.82
$15.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up